Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory - Seite 3

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS NEWS RELEASE.

For further information, please contact:
Dr. Fred D. Sancilio, CEO

Lobe Sciences Ltd.
Investor and Media
[e-mail]

Phone: [phone]

Email: [e-mail]
Website: www.lobesciences.com

SOURCE: Lobe Sciences Ltd.

View the original press release on ACCESS Newswire


The Lobe Sciences Stock at the time of publication of the news with a fall of -15,38 % to 0,055EUR on CSE stock exchange (28. Juli 2025, 22:04 Uhr).